FDA NDC Directory · JSON-LD · Markdown

Icatibant

NDC 63323-574 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Labeler / ManufacturerFresenius Kabi USA, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA208317
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsICATIBANT ACETATE (10 mg/mL)
Marketing started20201115
Package count2

External sources

Source: openFDA. Public-domain (CC0).